Blu – Pagina 17 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Aprile 29, 2026 Alice Lione

Novel OGTT metrics do not provide incremental predictive value beyond conventional glycemic criteria for remission of prediabetes in individuals with impaired fasting glucose: results from the PREVIEW trial

Zhu R, Guo J, Stratton G, et al.
Cardiovasc Diabetol. Pub. online 22 Apr 2026.

Leggi

Aprile 29, 2026 Alice Lione

Evaluation of large language models for carbohydrate counting in type 1 diabetes mellitus: a comparative study with patient estimations

Soyer AK, Akarsu GÇ, Yelli BD, et al.
Diabetes Res Clin Pract. Pub. online 25 Apr 2026.

Leggi

Aprile 29, 2026 Alice Lione

Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension

Moon JS, Han KA, Yu JM, et al.
Diabetes Res Clin Pract. Pub. online 24 Apr 2026.

Leggi

Aprile 26, 2026 Alice Lione

Age- and sex-specific trends in dementia mortality among people with and without diabetes: a multi-country population-based analysis

Mehta K, Morton JI, Chen L, et al.
Diabetologia. Pub. online 21 Apr 2026.

Leggi

Aprile 26, 2026 Alice Lione

Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial

Wilmot EG, Moore P, Sathyapalan T, et al.
Lancet Diabetes Endocrinol. Pub. online 23 Apr 2026.

Leggi

Aprile 26, 2026 Alice Lione

Efficacy, safety and PK of once-daily oral semaglutide 25 mg for obesity with and without type 2 diabetes in comparison with subcutaneous semaglutide 2.4 mg: a model-informed drug development approach

Overgaard RV, Birkhan O, Rathor N, et al.
Diabetes Obes Metab. Pub. online 23 Apr 2026.

Leggi

Aprile 26, 2026 Alice Lione

The role of continuous glucose monitoring for diagnosis of gestational diabetes: exploring the potential

Crowley M, Newman C, Dunne FP
BMC Med. Pub. online 21 Apr 2026.

Leggi

Aprile 26, 2026 Alice Lione

Outcomes with finerenone by baseline treatment goals in type 2 diabetes and chronic kidney disease: a FIDELITY analysis

Neves JS, Leite AR, Vasques-Nóvoa F, et al.
Diabetes Obes Metab. Pub. online 24 Apr 2026.

Leggi

Aprile 26, 2026 Alice Lione

Oral glucose absorption is enhanced in early metabolic dysfunction-associated steatotic liver disease

Tricò D, Wu T, Cimbalo N, et al.
Diabetologia. Pub. online 21 Apr 2026.

Leggi

Aprile 26, 2026 Alice Lione

Gene therapy and gene editing in type 1 diabetes: CRISPR-based β-cell replacement and treg immune modulation approaches

Lin TM, Chang HF, Lin TC, et al.
Diabetes Obes Metab. Pub. online 23 Apr 2026.

Leggi